4195 — Genomics Bioscience & Technology Co Income Statement
0.000.00%
Last trade - 00:00- TWD1.37bn
- TWD1.87bn
- TWD708.38m
Annual income statement for Genomics Bioscience & Technology Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 390 | 419 | 396 | 518 | 708 |
| Cost of Revenue | |||||
| Gross Profit | 110 | 136 | 120 | 157 | 231 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 429 | 453 | 531 | 667 | 793 |
| Operating Profit | -39.3 | -33.5 | -135 | -149 | -84.1 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 12.1 | 72.3 | -168 | -235 | -67.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 12.1 | 71.6 | -168 | -235 | -67.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 18.7 | 71.6 | -168 | -223 | -39.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 18.7 | 71.6 | -168 | -223 | -39.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.559 | 1.12 | -1.88 | -2.94 | -0.584 |
| Dividends per Share |